GHK-Cu 100mg

GHK (Gly-His-Lys) without copper is a simple tripeptide with a strong affinity for Cu(II) ions (log stability constant ~16.2), while GHK-Cu is the pre-formed 1:1 copper-peptide complex with distinct biological activity profiles. Copper-free GHK can chelate copper from surrounding media or biological fluids, making its effects dependent on ambient copper availability, which introduces an uncontrolled variable in experimental systems. Pre-complexed GHK-Cu delivers a defined copper payload directly to tissues and activates copper-dependent enzymatic pathways including lysyl oxidase (collagen crosslinking) and superoxide dismutase immediately upon cellular uptake. For reproducible research outcomes, GHK-Cu is preferred because the copper:peptide stoichiometry is fixed at synthesis, whereas copper-free GHK may produce variable results depending on the copper content of the culture medium or biological matrix used.

GHK-Cu's copper coordination complex can undergo structural rearrangement during freezing as ice crystal formation concentrates solutes and shifts local pH, potentially causing copper dissociation from the peptide and subsequent loss of biological activity upon thawing. At 4°C, the lyophilized powder and the coordination geometry remain stable without the mechanical stress of ice crystal formation in any residual moisture. Additionally, repeated freeze-thaw cycles are particularly damaging to metal-peptide complexes because the copper(II) ion can catalyze oxidative damage to the histidine imidazole ring during the transient concentration spikes that occur at ice-liquid interfaces. Protection from light is also specified because UV radiation can photo-reduce Cu(II) to Cu(I), which has different coordination chemistry and generates reactive oxygen species that degrade the peptide backbone.

Dissolve the 100mg lyophilized powder in sterile water to the desired concentration, typically 5-50 mg/mL depending on the application, by adding water slowly and swirling gently until the characteristic blue color is uniform throughout the solution with no undissolved particles. Do not use phosphate-buffered saline (PBS) at high concentrations, as phosphate can compete with the peptide for copper coordination at elevated temperatures, potentially displacing the metal. The reconstituted solution should be stored at 4°C protected from light and used within 14 days. For cell culture applications, prepare fresh dilutions into serum-free media immediately before use, as serum albumin and transferrin in complete media can sequester the copper ion over extended incubation periods, altering the effective GHK-Cu concentration.

GHK-Cu exists as a 1:1 copper(II):peptide complex in which the Cu(II) ion is coordinated by the glycine terminal amino group, the amide nitrogen between glycine and histidine, the histidine imidazole nitrogen, and the lysine side chain amino group in a square planar arrangement. This defined stoichiometry means each molecule delivers exactly one copper ion, allowing researchers to calculate precise copper concentrations in their experimental systems — a critical consideration since copper is biologically active at nanomolar concentrations but cytotoxic at micromolar levels. If excess free copper were present in a poorly manufactured preparation, it could generate hydroxyl radicals via Fenton-type chemistry and produce artifactual oxidative stress in cell cultures.

Gene expression profiling studies, particularly the Broad Institute Connectivity Map analysis published by Pickart and colleagues, demonstrated that GHK-Cu modulates the expression of approximately 4,000 human genes, representing roughly 6% of the human genome. The upregulated gene clusters are enriched in extracellular matrix components (collagens I and III, decorin, elastin), antioxidant defense systems (superoxide dismutase, glutathione-related enzymes), DNA repair pathways, and anti-inflammatory mediators including IL-10 and TGF-beta family members. Concurrently, GHK-Cu downregulates pro-inflammatory cytokines (IL-6, TNF-alpha), pro-fibrotic mediators, and several metalloproteinases involved in excessive tissue degradation. This bidirectional gene modulation profile — simultaneously promoting tissue remodeling while suppressing destructive inflammation — is unusually broad for a tripeptide and distinguishes GHK-Cu from most single-target peptide ligands in the research literature.

GHK-Cu is present in human plasma at approximately 200 ng/mL (roughly 500 nM) in young adults around age 20, declining to approximately 80 ng/mL (roughly 200 nM) by age 60, representing a 60% reduction over four decades. This age-related decline was first characterized through copper-binding peptide fractionation studies of human serum and correlates temporally with decreased wound healing capacity, reduced collagen synthesis rates, and diminished antioxidant enzyme activity observed in aging tissues. GHK-Cu has also been detected in saliva and urine, suggesting it is a systemically distributed endogenous peptide rather than a purely circulatory factor. The declining plasma concentration provides a quantitative framework for researchers designing dose-response studies, as physiologically relevant in vitro concentrations should bracket the 200-500 nM range to model the young-to-aged spectrum.

AHK-Cu (Ala-His-Lys-Cu) is a related copper tripeptide found in human plasma that shares the His-Lys copper-binding motif but substitutes alanine for glycine at the N-terminal position, resulting in a slightly different copper coordination geometry and a distinct (though overlapping) gene expression modulation profile. In comparative studies, GHK-Cu demonstrates stronger collagen-stimulating activity and broader gene modulation scope than AHK-Cu, likely due to differences in copper binding affinity and cellular uptake kinetics. Other copper peptides studied include DAHK (the N-terminal copper-binding domain of human serum albumin), which has high copper affinity but primarily serves a copper transport rather than signaling function. For tissue remodeling and regenerative biology research, GHK-Cu remains the most extensively characterized copper peptide, with over 60 years of published data since its initial discovery by Pickart in the 1970s from human albumin hydrolysates.